Aromatase regulation and breast cancer

Clinical Endocrinology

Volumn 54, Issue 5, 2001, Pages 563-571

  Reed, M J ^a   Purohit, A ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYESTRADIOL; ANDROSTENEDIONE; AROMATASE; AROMATASE INHIBITOR; CYTOKINE; ESTROGEN; ESTRONE; LETROZOLE; PROSTAGLANDIN E2;

AROMATIZATION; BREAST CANCER; CARCINOGENESIS; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LOCALIZATION; ENZYME REGULATION; FIBROBLAST; GENE ACTIVITY; GENE EXPRESSION; HORMONE BLOOD LEVEL; HORMONE SYNTHESIS; HUMAN; MODEL; NONHUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVIEW; TUMOR GROWTH; TUMOR LOCALIZATION;

ADULT; ANIMALS; AROMATASE; AROMATASE INHIBITORS; ARYL HYDROCARBON HYDROXYLASES; BREAST; BREAST NEOPLASMS; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 ENZYME SYSTEM; CYTOKINES; DIETARY FATS; DINOPROSTONE; ENZYME ACTIVATION; ENZYME INHIBITORS; ESTRADIOL; ESTROGENS; FEMALE; FIBROBLASTS; HUMANS; MIDDLE AGED; NITRILES; OBESITY; PESTICIDES; STEROID 16-ALPHA-HYDROXYLASE; STEROID HYDROXYLASES; TRIAZOLES;

EID: 0035723494     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2001.01276.x     Document Type: Review

References (68)

1. Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture
2. Prostaglandins and breast cancer
3. On the significance of in situ production of oestrogens in human breast cancer tissues
4. Pharmacology of inhibitors of estrogen biosynthesis
5. The relationship between 17 β-hydroxy-steroid dehydrogenase activity and oestrogen concentrations in human breast tumours and in normal breast tissue
6. A reassessment of the role of breast tumour aromatase
7. Effects of pesticides on the ratio of 16α/2-hydroxyestrone: A biological marker of breast cancer risk
8. 2-Hydroxyestrone: The 'good' estrogen
9. Angiogenesis antagonists: Current clinical trials
10. A link between breast cancer and local estrogen synthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription
11. Oestrone sulphatase activity in normal and malignant breast tissues: Relationship with tumour location
12. Adverse life events and breast cancer: Case controlled study
13. Elevated oestrogen and reduced testosterone levels in the serum of male septic shock patients
14. Detection of intratumoral aromatase in breast carcinomas
15. Influence of body weight on estradiol metabolism in young women
16. Estrone and estradiol content in human breast tumours: Relationship to estradiol receptors
17. The endogenesis oestrogen metabolite 2-methoxyestradiol inhibits angiogenesis and suppresses tumour growth
18. Sources of estrogen production in postmenopausal women
19. Plasma precursors of estrogen II. Correlation of the extent of conversion of plasma androstenedione to estrone with age
20. Increased adipose tissue expression of tumor necrosis factor α in human obesity and insulin resistance
21. Steroid hormones and human cancer
22. The role of tissue steroids in regulating aromatase and oestradiol 17β-hydroxy-steroid dehydrogenase activities in breast and endometrial cancer
23. Oestrogen uptake and metabolism in vivo
24. Macrophages in human breast disease: A quantitative immunohistochemical study
25. Sex hormone changes induced by the parasite lead to feminization of the male host in murine Taenia crassiceps cysticercosis
26. The effect of a low fat diet on estrogen metabolism
27. Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers
28. Stimulation of aromatase activity in breast fibroblasts by tumor necrosis factor α
29. Apoptosis inducing agents cause rapid shedding of tumor necrosis factor receptor 1
30. Tissue-specific and hormonally controlled alternative promoters regulate aromatase P450 gene expression in human ovary and fetal tissue
31. Direction of estradiol metabolism as a control of its hormonal action: Uterotrophic activity of estradiol metabolites
32. Aromatase inhibitors
33. Biology of aromatase inhibitors: Pharmacology/endocrinology within the breast
34. The importance of local synthesis of estrogen within the breast
35. Relationship between tumour aromatase activity, tumour characteristics and response to therapy
36. Subcutaneous adipose tissue releases interleukin-6 but not tumor necrosis factor-α, in vivo
37. Serum tumour necrosis factor levels in patients with infectious diseases and septic shock
38. Aromatase activity in adipose tissue from breast quadrants: A link with tumour site
39. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood
40. Importance of oestrogen sulphates in breast cancer
41. Regulated CYP19 aromatase transcription in breast stromal fibroblasts
42. Aromatase activity and interleukin-6 production by normal and malignant breast tissues
43. Inhibition of tumour necrosis factor α-stimulated aromatase activity by microtubule-stabilizing agents, paclitaxel and 2-methyoxyestradiol
44. Breast cancer and the role of cytokines in regulating estrogen synthesis: An emerging hypothesis
45. In situ oestrone synthesis in normal breast and breast tumour tissue: Effect of treatment with 4-hydroxyandrostenedione
46. Concentrations of oestrone and 4-hydroxy androstenedione in malignant and normal breast tissues
47. Interleukin-1 and interleukin-6 in breast cyst fluid: Their role in regulating aromatase activity in breast cancer cells
48. Hormones, peripherally activated prohormones and regulation of Th1/Th2 balance
49. Use of aromatase inhibitors in breast cancer
50. Stromal spindle cells contain aromatase in human breast tumours
51. Intratumoral aromatase in human breast, endometrial and ovarian malignancies
52. Immunolocalisation of aromatase and other steroidogenic enzymes in human breast disorders
53. The cytotoxic effects of estradiol-17 β, catecholestradiols and methoxyestradiols on dividing MCF-7 and HeLa cells
54. 2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators
55. Role of extraglandular estrogen in human endocrinology
56. IL-6sR: Release from MCF-7 breast cancer cells and role in regulating peripheral oestrogen synthesis
57. Control of aromatase in breast tumours: The role of the immune system
58. 2
59. Estrogens in tissues: Uptake from the peripheral circulation or local production
60. Endogenous steroid hormones and local aromatase activity in the breast
61. Presence of alternatively spliced transcripts of aromatase gene in human breast cancer
62. Endogenous concentrations and sub cellular distribution of estrogens in normal and human malignant human breast tissue
63. Aromatase, 17 β-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women
64. Increase of plasma IL-6 concentrations with age in healthy subjects
65. In situ aromatization enhances breast tumor estradiol levels and cellular proliferation
66. Characterisation of the sequences of the human CYP19 aromatase gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes
67. 2 via cyclic AMP leading to activation of promoter II of the CYP19 aromatase gene
68. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis